Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/UK EMC/Nintedanib 100 mg Soft Capsules

Approved

STANDARD

Nintedanib 100 mg Soft Capsules

Tillomed Laboratories Ltd🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: b0b0686a5e767351
Company: Tillomed Laboratories Ltd
Type: Standard

Approval Details

Approval Id: b0b0686a5e767351
Drug Approval Emc Name: Nintedanib 100 mg Soft Capsules
Drug Name: Nintedanib 100 mg Soft Capsules
Company Name: Tillomed Laboratories Ltd
Company Address: 220 Butterfield, Great Marlings, Luton, LU2 8DL, UK
Company Website: http://www.tillomed.com/
Company Telephone: +44 (0)1480 402 400
Company Medical Info Direct Line: +44 (0)1480 402 400 [option 2]
Company Medical Info Email: [email protected]
Company Customer Care Direct Line: +44 (0)1480 402 400 [option 1]
Company Stock Availability: +44 (0)1480 402 400 [option 1]
Atc Code: L01EX09
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

b0b0686a5e767351

Type

Standard

Back to UK EMC Approvals

Nintedanib 100 mg Soft Capsules - UK EMC Drug Approval Details